Sign In
Buy TGTX
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
Why TG Therapeutics Stock Was a Solid Winner This Week
05:27pm, Friday, 30'th Dec 2022
The company scored a giant victory on the regulatory front.
Analyst Ratings for TG Therapeutics
03:02pm, Friday, 30'th Dec 2022 Benzinga
Within the last quarter, TG Therapeutics (NASDAQ:TGTX) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
1
0
1
1
Last
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
03:01pm, Friday, 30'th Dec 2022 Benzinga
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.
H
Company News for Dec 30, 2022
02:30pm, Friday, 30'th Dec 2022 Zacks Investment Research
Companies in The News Are: IMGN, TGTX, TSLA, MSFT
Shaw Communications, Enovix And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
12:52pm, Friday, 30'th Dec 2022 Benzinga
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Shaw Communications Inc. (NYSE: SJR) shares jumped 10.3% to $29.11 in p
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
07:47pm, Thursday, 29'th Dec 2022 Benzinga
Wednesday, the FDA approved TG Therapeutics Inc's (NASDAQ: TGTX) Briumvi (ublituximab-xiiy) for relapsing forms of multiple sclerosis (RMS).
Briumvi is the first and only anti-CD20 monoclonal antibo
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
06:14pm, Thursday, 29'th Dec 2022 Benzinga
Gainers
Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Quotient Limited (NASDAQ: QTNT) shares jumped 124% to $0.5382 afte
HC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know
05:01pm, Thursday, 29'th Dec 2022 Benzinga
HC Wainwright & Co. has decided to maintain its Buy rating of TG Therapeutics (NASDAQ:TGTX) and raise its price target from $19.00 to $24.00.
Shares of TG Therapeutics are trading up 24.47% over the l
B of A Securities Maintains Underperform Rating for TG Therapeutics: Here's What You Need To Know
05:00pm, Thursday, 29'th Dec 2022 Benzinga
B of A Securities has decided to maintain its Underperform rating of TG Therapeutics (NASDAQ:TGTX) and raise its price target from $5.00 to $6.00.
Shares of TG Therapeutics are trading up 24.47% over
TG Therapeutics (TGTX) Gets FDA Nod for Multiple Sclerosis Drug
03:39pm, Thursday, 29'th Dec 2022 Zacks Investment Research
The FDA approves TG Therapeutics' (TGTX) Briumvi (ublituximab-xiiy) for treating relapsing forms of multiple sclerosis. The company plans to launch the drug in the first quarter of 2023. Stock up.
Tesla To $250? Here Are 10 Other Price Target Changes For Thursday
02:09pm, Thursday, 29'th Dec 2022 Benzinga
Morgan Stanley cut Tesla, Inc. (NASDAQ: TSLA) price target from $330 to $250. Morgan Stanley analyst Adam Jonas maintained an Overweight rating on the stock. Tesla shares rose 4.4% to $117.65 in p
Tesla, Hyzon Motors And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
01:03pm, Thursday, 29'th Dec 2022 Benzinga
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Hyzon Motors Inc. (NASDAQ: HYZN) shares climbed 12.9% to $1.58 in pre
TG Therapeutics (TGTX) Gets FDA Nod for Multiple Sclerosis Drug
12:02pm, Thursday, 29'th Dec 2022
The FDA approves TG Therapeutics' (TGTX) Briumvi (ublituximab-xiiy) for treating relapsing forms of multiple sclerosis. The company plans to launch the drug in the first quarter of 2023.
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
11:36am, Thursday, 29'th Dec 2022 Benzinga
Gainers
Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nas
What's Going On With TG Therapeutics Shares - TG Therapeutics (NASDAQ:TGTX)
09:54am, Thursday, 29'th Dec 2022
TG Therapeutics Inc TGTX shares are trading higher by 9.34% to $9.25 Thursday morning. The company on Wednesday revealed FDA approval of ublituximab.
